This is a positive commercial signal for LIBERTY adoption trajectory, but without pricing or volume data the materiality is low. Monitor upcoming quarterly filings for revenue contribution from new accounts and any disclosure of total system placements.
Price Chart
Executive Summary
Microbot Medical announced its first North Carolina-based healthcare system customer for the LIBERTY Endovascular Robotic System, expanding geographic penetration into the South-Atlantic region. This is a commercial milestone but no revenue, unit volume, or contract value was disclosed.
Key Facts
- Secured first North Carolina-based customer, a leading academic center with a multi-hospital network covering the entire state
- Customer is described as the first user in the South-Atlantic region, broadening penetration from the southeast, mid-Atlantic, and northeast U.S.
- No financial terms, unit sales, or revenue figures disclosed
- CEO Harel Gadot cited 'pace of increase in new accounts' following full market release of LIBERTY system
Financial Impact
No financial figures disclosed; customer count growth is qualitative only
Risk Factors
- No revenue or unit volume disclosed — commercial traction remains unquantified
- Forward-looking statements about market penetration are not guaranteed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-026769 |
| Exhibit: ex99-1.htm | 0001493152-26-026769 |
| Document: 0001493152-26-026769-index-headers.html | 0001493152-26-026769 |
| Document: 0001493152-26-026769-index.html | 0001493152-26-026769 |
| Document: 0001493152-26-026769.txt | 0001493152-26-026769 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.9739 $0.9417 | ▼ −3.31% | ▼ −4.02% | $0.9700 (−0.40%) |
Oct 20, 2026 6d ago | 8-K | $0.9475 $0.9401 | ▼ −0.78% | ▼ −1.31% | $0.9700 (+2.37%) |
Oct 6, 2026 20d ago | 8-K | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9700 (−9.35%) |
Oct 6, 2026 20d ago | Press Release | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9700 (−9.35%) |
Sep 28, 2026 28d ago | 8-K | $1.25 $1.25 | ▼ −0.40% | ▼ −0.22% | $0.9700 (−22.40%) |
Aug 11, 2026 10w ago | 8-K | $1.68 $1.74 | ▲ +3.27% | ▲ +3.02% | $0.9700 (−42.26%) |
Jul 21, 2026 13w ago | 8-K | $1.80 $1.77 | ▼ −1.67% | ▼ −1.55% | $0.9700 (−46.11%) |
Jul 7, 2026 15w ago | 8-K | $1.90 $1.87 | ▼ −1.58% | ▼ −1.27% | $0.9700 (−48.95%) |
Jun 30, 2026 16w ago | 8-K | $1.95 $1.91 | ▼ −2.05% | ▼ −1.92% | $0.9700 (−50.26%) |
Jun 16, 2026 18w ago | 8-K | $1.82 $1.88 | ▲ +3.30% | ▲ +4.55% | $0.9700 (−46.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers